PRINCETON, NJ - Jun 3, 2015 - Certara®, the global biosimulation technology-enabled drug development consultancy, today announced that it is endowing a new three-year, full-time position – the Certara Lecturer in Precision Dosing – at the Manchester Pharmacy School, The University of Manchester, England
New academic collaboration will help to
advance precision medicine efforts to deliver the right treatment
to patients at the right time
PRINCETON, NJ - Jun 3, 2015 - Certara®, the global biosimulation
technology-enabled drug development consultancy, today announced
that it is endowing a new three-year, full-time position - the
Certara Lecturer in Precision Dosing - at the Manchester Pharmacy
School, The University of Manchester, England. This lectureship is
intended to advance teaching and research into individual dose
optimization modeling, and to demonstrate its application to
cancer, pediatric, and biologic therapies.
This new lecturer will work closely with the clinical pharmacy,
clinical pharmacology, and quantitative proteomics research groups
at The University of Manchester to raise the profile of precision
dosing within the universitys precision medicine initiative. This
staff member will also lead post-graduate modeling and simulation
programs.
Our work with global biopharm companies and regulatory agencies
demonstrates the advantages of using biosimulation to answer
precision dosing questions for specific cohorts such as pediatric
or geriatric patients, women who are pregnant, or patients with
co-morbidities, said Certara Chief Executive Officer Edmundo
Muniz, M.D., Ph.D. Through this new academic collaboration with
The University of Manchester, we expect to further the field and
make precision dosing for all individuals a reality.
Precision medicine has the potential to improve dramatically
the healthcare outcomes for individual patients around the world,
added Professor Kay Marshall B.Pharm., FRPharm.S., PhD., MBA, head
of Manchester Pharmacy School. We are delighted to have this
opportunity to partner with Certara and help prepare our students
for exciting pharmacometric careers by providing them with
individual dose optimization modeling experience.
This new lecturer will become a member of the Systems
Pharmacology Group within Manchester Pharmacy School. The
postholder will report to the Head of School and be mentored by
Professor Amin Rostami, Pharm.D., Ph.D., professor of systems
pharmacology at The University of Manchester, and Certaras Chief
Scientific Officer.
About The University of Manchester
The University of Manchester, a member of the prestigious
Russell Group of British universities, is the largest and most
popular university in the UK. It has 20 academic schools and
hundreds of specialist research groups undertaking pioneering
multi-disciplinary teaching and research of worldwide
significance.
The University of Manchester is one of the countrys major
research institutions, rated fifth in the UK in terms of research
power (REF 2014), and has had no fewer than 25 Nobel laureates
either work or study there. The University had an annual income of
£886 million in 2013/14.
www.manchester.ac.uk
About Certara
Certara is a global biosimulation technology-enabled drug
development consultancy. Its customers include hundreds of
biopharmaceutical companies around the globe, together with several
regulatory agencies. Certaras solutions, which span the discovery,
preclinical and clinical stages of drug development, enable
data-driven decisions, leading to more precisely designed trials
with a reduced risk of failure and improved subject safety. For
more information, visit www.certara.com.